On January 8, 2018 Roche reported that it will publish its Full Year Results for 2017 prior to the opening of the Swiss Stock Exchange on Thursday, 1 February 2018 (Press release, Hoffmann-La Roche, JAN 8, 2018, View Source [SID1234523006]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
7:00 CET / 6:00 GMT / 1:00 AM EST / 10:00 PM PST (evening before)
Release will be e-mailed and posted on the Roche IR website.
Presentation slides will be posted on the Roche IR website.
We would like to invite all interested parties to participate or dial in to the event outlined below.
Thursday, 1 February 2018, London
The Full Year Presentation followed by Q&A and additional break-out sessions will be held at the London Stock Exchange, The Theatre, 10 Paternoster Square, London EC4M 7LS map
Presenters:
Severin Schwan, CEO Roche Group
Daniel O’Day, CEO Roche Pharmaceuticals
Roland Diggelmann, CEO Roche Diagnostics
Alan Hippe, Chief Financial and IT Officer
Meeting information:
1 February 2018
Time (GMT):
14:30 Registration
15:00 Meeting starts
17:30 Meeting ends, followed by a buffet reception
Break-out sessions covering the topics Strategy, Finance & Accounting, Pharmaceuticals and Diagnostics will be held following the main Q&A.
Following the event we would also like to invite you to drinks and canapés to give you the opportunity to speak to management more informally.
Please make sure you have identification and allow enough time to go through the London Stock Exchange security check.
To register for the event, please follow the link.
This presentation can also be accessed through a live video webcast.
In order to receive your personal dial-in details and expedite your access to the conference call, please pre-register under this link.
If you have not pre-registered please find the dial-in numbers below, we recommend you to dial in to the conference 10-15 min prior to the scheduled start:
+41 (0) 58 310 50 00 (Europe and ROW) or
+44 (0) 207 107 0613 (UK) or
+1 (1) 631 570 5613 (USA)
Replay
A replay of the video webcast will be available on demand on the Roche website.